Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer
Prostate cancer is the most common cancer in men in the Western world. Therefore, its early diagnosis in particular, which is mainly based on serum prostate-specific antigen (PSA), has gained attention in several fields of research. New biomarkers in serum and urine have been described, for example,...
Format: | eBook |
---|---|
Language: | English |
Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2017
|
Subjects: | |
Online Access: | Open Access: DOAB, download the publication Open Access: DOAB: description of the publication |
Similar Items
-
An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
by: Helen Saxby, et al.
Published: (2020-07-01) -
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
by: Mirko Signorelli, et al.
Published: (2020-04-01) -
Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine
by: James Meehan, et al.
Published: (2021-07-01) -
Limitations of Explainability for Established Prognostic Biomarkers of Prostate Cancer
by: Kalifa Manjang, et al.
Published: (2021-07-01) -
Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
by: Shengri Tian, et al.
Published: (2020-08-01)